Breast cancer remains the most common cancer in women, with a lifetime risk of almost 11% (one in nine)in the UK. There has been an overall increase in the incidence of breast cancer but in the UK mortality has fallen by over 30% in the last decade. It is likely that this is due to the widespread introduction of tamoxifen in treatment regimens and the introduction of breast screening. Obstetricians will see an increasing number of women who are pregnant or seeking pregnancy after treatment for breast cancer.This guideline updates the RCOG advice published in July 1997 and 2004.
This guideline can be downloaded as a pdf using the link below.